drugset / Trial / NCT02032563

Study of the ICG Distribution in Breast Tumours or in Axillary Lymph Nodes of Patients After Neoadjuvant Therapy

NCT02032563

Phase 2 Unknown 20 enrolled Jules Bordet Institute
NaSingle-groupOpen-labelDiagnostic

Summary

We will verify if IV injected ICG may colour breast tumors and axillary lymph nodes after neoadjuvant therapy (chemo- or hormonotherapy)

Timeline

Start
2013-12
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent 0.25 mg/kg Intravenous

Indications